Covington & Burling (Washington)

Andrew D. Lazerow

Covington & Burling (Washington)
Lawyer (Partner)

Andrew Lazerow represents domestic and international clients in some of their most important complex commercial litigation, including antitrust class actions and competitor disputes, securities fraud class actions, and complex commercial disputes. Mr. Lazerow regularly represents leading pharmaceutical clients in antitrust class actions arising from settlements of Hatch-Waxman ANDA patent litigation.


Auteurs associés

Covington & Burling (Washington)
Covington & Burling (London)
Covington & Burling (Brussels)
Covington & Burling (Washington)
Covington & Burling (Washington)


66 Bulletin

Thomas Barnett, Deborah A. Garza, John D. Graubert, Timothy C. Hester, Andrew D. Lazerow, John W. Nields, James J. O’Connell The US FTC brings a lawsuit in the pharmaceutical sector for monopolization based on patent litigation (AndroGel II)


The Federal Trade Commission has brought its first suit alleging anticompetitive conduct in connection with the prosecution and settlement of pharmaceutical patent litigation since the Supreme Court’s June 2013 decision in FTC v. Actavis. Although two commissioners dissented from the decision to (...)

Envoyer un message